AOA Dx
PrivateLast Round
Series A
Oct 12, 2023
Total Funding Raised
$46.8M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
AOA Dx operates in Healthcare & Life Sciences and is based in Denver, Colorado. Its latest recorded funding round was a Series A round in October 2023.
AOA Dx is a biotechnology company that develops an AI-enabled multi-omics liquid biopsy platform for the early detection of ovarian cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AOA Dx Comparables
Compare AOA Dx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PROMISS Diagnostics | 89% | |
| Mercy BioAnalytics | 86% | |
| ClearNote Health | 84% |
For institutional investors. Book with your work email.
AOA Dx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 12, 2023 | ||||
| Series A | Jul 1, 2023 | ||||
| Seed | Sep 13, 2022 | ||||
| Seed | Mar 1, 2022 | ||||
| Grant | Aug 16, 2021 | ||||
Pre Seed | Jun 28, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AOA Dx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SideCar Angels | Pre Seed |
| Canadian Institutes of Health Research | Grant |
| TBD Angels | Pre Seed |
| Gore Range Capital | Series A |
| Pioneer Fund | Pre Seed |
| Good Growth Capital | Series A |
| AlleyCorp | Seed, Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 44% MoM.
- Jan 1, 2026
Developing AKRIVIS GD™, an early-stage diagnostic for ovarian cancer.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardOct 19, 2026
At the MedTech Conference in Massachusetts, AOA Dx Inc receives TEAMFund's Global Health Innovation Award for pioneering lipidomics-based, non-invasive blood testing for early-stage cancer detection.
For institutional investors. Book with your work email.
AOA Dx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AOA Dx's valuation, stock price, and market status.
Is AOA Dx a public or private company?
AOA Dx is a private company.
What is the current stock price of AOA Dx?
AOA Dx is a private company, so its shares have no public market price. Caplight tracks AOA Dx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AOA Dx worth (valuation)?
Valuation information for AOA Dx is not publicly available.
Can I buy AOA Dx stock?
AOA Dx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AOA Dx's last funding round?
AOA Dx's most recent funding round was Series A on October 12, 2023.
Who are the main investors in AOA Dx?
Key investors in AOA Dx include Good Growth Capital, AlleyCorp, Avestria Ventures, Joyance Partners.
Will AOA Dx IPO soon?
No public IPO plans have been announced for AOA Dx.
How can I track AOA Dx secondary market activity?
Caplight tracks bids, offers, and trades in AOA Dx's shares on secondary markets.